Bruce George Haffty

Bruce George Haffty's AcademicInfluence.com Rankings

Bruce George Haffty

Philosophy

#5376

World Rank

#8153

Historical Rank

Logic

#2665

World Rank

#3687

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Bruce George Haffty's Degrees

Doctorate Medicine University of Medicine and Dentistry of New Jersey

Why Is Bruce George Haffty Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bruce George Haffty's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. (2013) (1069)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. (2006) (1019)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers (2010) (907)
Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. (2006) (841)
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). (2009) (615)
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer (2010) (526)
Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. (2006) (431)
VCAM-1 promotes osteolytic expansion of indolent bone micrometastasis of breast cancer by engaging α4β1-positive osteoclast progenitors. (2011) (426)
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. (2018) (392)
MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. (2009) (386)
Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. (1996) (368)
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. (1997) (363)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer. (2006) (322)
Accelerated partial breast irradiation consensus statement from the American Society for Radiation Oncology (ASTRO). (2009) (315)
Radiation field design in the ACOSOG Z0011 (Alliance) Trial. (2014) (306)
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status (2002) (304)
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline. (2011) (300)
True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. (2000) (285)
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. (2001) (281)
Quantitative Determination of Nuclear and Cytoplasmic Epidermal Growth Factor Receptor Expression in Oropharyngeal Squamous Cell Cancer by Using Automated Quantitative Analysis (2005) (275)
Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. (2000) (257)
Effect of radiotherapy after breast-conserving treatment in women with breast cancer and germline BRCA1/2 mutations. (2000) (257)
Adenoid cystic carcinoma: A retrospective clinical review (2001) (255)
Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. (2002) (222)
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients. (2011) (220)
Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms (2015) (219)
Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. (1996) (209)
Elf5 inhibits epithelial mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2/Slug (2012) (199)
Long‐term outcome after breast‐conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast (2005) (196)
Results of radical radiation therapy in clinical stage I, technically operable non-small cell lung cancer. (1987) (187)
Effectiveness of radiation therapy for older women with early breast cancer. (2006) (171)
Prognosis following local recurrence in the conservatively treated breast cancer patient. (1991) (170)
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. (1998) (169)
Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy (2010) (169)
Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. (2001) (159)
Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation. (2011) (158)
Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. (2000) (156)
First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity (2005) (149)
Chemotherapy as an adjunct to radiation in the treatment of squamous cell carcinoma of the head and neck: results of the Yale Mitomycin Randomized Trials. (1997) (141)
Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. (1993) (138)
Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials: EBCTCG (Early Breast Cancer Trialists' Collaborative Group) () Lancet 383:2127-2135, 2014§ (2014) (131)
The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? (2010) (127)
Positive sentinel nodes without axillary dissection: implications for the radiation oncologist. (2011) (126)
ACR Appropriateness Criteria Breast Cancer Screening. (2013) (126)
Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression (2017) (124)
Ipsilateral breast tumor recurrence after breast conservation therapy: outcomes of salvage mastectomy vs. salvage breast-conserving surgery and prognostic factors for salvage breast preservation. (2005) (119)
Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. (2006) (118)
Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. (2014) (117)
Negative margin status improves local control in conservatively managed breast cancer patients. (2000) (115)
BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. (1999) (114)
ACR Appropriateness Criteria Breast Cancer Screening. (2016) (113)
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway (2014) (112)
Mitomycin C: a prototype bioreductive agent. (1994) (112)
SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2 (2018) (111)
Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients. (2004) (110)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19805 patients, on behalf of MACH-NC group. (2016) (109)
BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer. (2001) (108)
Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. (2002) (104)
ACR appropriateness criteria on postmastectomy radiotherapy expert panel on radiation oncology-breast. (2009) (103)
Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 (2002) (101)
Breast-conserving therapy in the setting of collagen vascular disease. (2001) (101)
MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors. (2014) (100)
Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. (2005) (98)
Prognostic factors for local recurrence in the conservatively treated breast cancer patient: a cautious interpretation of the data. (1991) (98)
Evaluation of HER-2 neu oncoprotein expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: a case-control study. (1996) (96)
Local‐Regional Breast Cancer Recurrence: Prognostic Groups Based on Patterns of Failure (2002) (96)
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid Tumors (2017) (94)
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. (2004) (94)
Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. (1997) (94)
Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. (2000) (93)
Local recurrence versus new primary: clinical analysis of 82 breast relapses and potential applications for genetic fingerprinting. (1993) (93)
Postmastectomy radiotherapy: questions for the twenty-first century. (1998) (89)
Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients (2014) (88)
Conservative surgery and radiation therapy in breast carcinoma: local recurrence and prognostic implications. (1989) (86)
Standardization of estrogen receptor measurement in breast cancer suggests false-negative results are a function of threshold intensity rather than percentage of positive cells. (2011) (83)
Postmastectomy radiation and survival in older women with breast cancer. (2006) (83)
Conservative surgery and radiation in the treatment of synchronous ipsilateral breast cancers (1993) (81)
Association of nuclear localization of a long interspersed nuclear element-1 protein in breast tumors with poor prognostic outcomes. (2010) (81)
Cyclin d1 is a valuable prognostic marker in oropharyngeal squamous cell carcinoma. (2005) (79)
Five‐year outcome of patients classified using the American Society for Radiation Oncology consensus statement guidelines for the application of accelerated partial breast irradiation (2010) (79)
Effectiveness of radiation therapy in older women with ductal carcinoma in situ. (2006) (79)
Phosphorylation of Akt (Ser473) Predicts Poor Clinical Outcome in Oropharyngeal Squamous Cell Cancer (2007) (79)
4–50 Ipsilateral Breast Tumor Recurrence (IBTR) After Breast-Conserving Treatment for Early Breast Cancer: Risk Factors and Impact on Distant Metastases (2007) (78)
Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma. (1999) (78)
Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation. (2008) (78)
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. (2014) (77)
Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis (2016) (77)
Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. (1998) (75)
Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). (2003) (75)
Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial. (2017) (75)
Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumors 5 cm and larger. (2006) (74)
Internal mammary nodal irradiation in conservatively-managed breast cancer patients: is there a benefit? (1999) (73)
Adoption of hypofractionated whole-breast irradiation for early-stage breast cancer: a National Cancer Data Base analysis. (2014) (72)
Descriptions and outcomes of insertion techniques of a breast brachytherapy balloon catheter in 1403 patients enrolled in the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. (2005) (71)
Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care. (2011) (71)
Supply and Demand for Radiation Oncology in the United States: Updated Projections for 2015 to 2025. (2016) (70)
Breast conservation therapy without axillary dissection. A rational treatment strategy in selected patients. (1993) (70)
Regional nodal irradiation in the conservative treatment of breast cancer. (1990) (70)
Pregnancy and lactation after breast‐conserving therapy for early stage breast cancer (1994) (69)
Possession of ATM sequence variants as predictor for late normal tissue responses in breast cancer patients treated with radiotherapy. (2007) (69)
Frequent alterations of Smad signaling in human head and neck squamous cell carcinomas: a tissue microarray analysis. (2003) (69)
The conservative management of Paget's disease of the breast with radiotherapy (1997) (68)
Salvage treatment for local recurrence following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast. (1994) (67)
Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women (2003) (67)
Cullin3–KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression (2016) (67)
p53-dependent BRCA1 nuclear export controls cellular susceptibility to DNA damage. (2011) (65)
Association of Radiotherapy Boost for Ductal Carcinoma In Situ With Local Control After Whole-Breast Radiotherapy (2017) (64)
Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. (2006) (64)
Quantitative In Situ Measurement of Estrogen Receptor mRNA Predicts Response to Tamoxifen (2012) (63)
The Hormonal Receptor Status in Breast Cancer can be Altered by Neoadjuvant Chemotherapy: A Meta-Analysis (2011) (63)
Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. (2001) (63)
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups. (2009) (62)
Initial Outcomes for Patients Treated on the American Society of Breast Surgeons MammoSite Clinical Trial for Ductal Carcinoma-In-Situ of the Breast (2006) (62)
Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to white women (2005) (62)
Salvage treatment for local recurrence after breast‐conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast (2001) (61)
Effects of Breast‐Conserving Therapy on Lactation After Pregnancy (2005) (59)
Regional nodal recurrence in breast cancer patients treated with conservative surgery and radiation therapy (BCS+RT). (2006) (58)
Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence. (1998) (58)
Six-Year Analysis of Treatment-Related Toxicities in Patients Treated with Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial (2012) (58)
Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. (2008) (57)
Autophagy inhibition by chloroquine sensitizes HT-29 colorectal cancer cells to concurrent chemoradiation. (2014) (57)
ACR appropriateness criteria palpable breast masses. (2013) (57)
53BP1 functions as a tumor suppressor in breast cancer via the inhibition of NF-κB through miR-146a. (2012) (56)
A comparison of five immunohistochemical biomarkers and HER‐2/neu gene amplification by fluorescence in situ hybridization in white and Korean patients with early‐onset breast carcinoma (2003) (56)
Effect of Travel Distance and Time to Radiotherapy on Likelihood of Receiving Mastectomy (2015) (56)
Postchemotherapy MRI Overestimates Residual Disease Compared with Histopathology in Responders to Neoadjuvant Therapy for Locally Advanced Breast Cancer (2006) (55)
Geographic analysis of the radiation oncology workforce. (2012) (55)
Reduction in Tumor Volume by Cone Beam Computed Tomography Predicts Overall Survival in Non-Small Cell Lung Cancer Treated With Chemoradiation Therapy. (2015) (54)
Repeat breast‐conserving surgery for in‐breast local breast carcinoma recurrence (2004) (54)
Conservative surgery with radiation therapy in clinical stage I and II breast cancer. Results of a 20-year experience. (1989) (53)
Adjuvant whole‐abdominal radiation therapy in uterine papillary serous carcinoma (1991) (53)
Concurrent chemo-radiotherapy with mitomycin C compared with porfiromycin in squamous cell cancer of the head and neck: final results of a randomized clinical trial. (2005) (53)
Locoregional Recurrence of Triple-negative Breast Cancer After Breast-conserving Surgery and Radiation (2009) (51)
Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial (2012) (51)
Defining Molecular Phenotypes of Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma (2009) (51)
Molecular markers for prognosis after isolated postmastectomy chest wall recurrence (2004) (51)
Prognostic Significance of Cyclooxygenase-2 in Oropharyngeal Squamous Cell Carcinoma (2004) (51)
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. (1996) (50)
Pragmatic randomised clinical trial of proton versus photon therapy for patients with non-metastatic breast cancer: the Radiotherapy Comparative Effectiveness (RadComp) Consortium trial protocol (2019) (50)
Local recurrence of breast cancer after breast conservation therapy in patients examined by means of stereotactic core-needle biopsy. (2002) (50)
Ductal carcinoma in situ treated with breast‐conserving surgery and radiotherapy: A comparison with ECOG study 5194 (2011) (49)
Evaluation of current consensus statement recommendations for accelerated partial breast irradiation: a pooled analysis of William Beaumont Hospital and American Society of Breast Surgeon MammoSite Registry Trial Data. (2013) (49)
Improvement in interobserver accuracy in delineation of the lumpectomy cavity using fiducial markers. (2010) (48)
Molecular markers in clinical radiation oncology (2003) (48)
Lobular carcinoma in situ as a component of breast cancer: the long-term outcome in patients treated with breast-conservation therapy. (1998) (48)
Inhibition of Filamin-A Reduces Cancer Metastatic Potential (2012) (47)
MTDH Activation by 8 q 22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast Cancer (2008) (47)
Conservative management of Paget disease of the breast with radiotherapy (2003) (47)
Long‐term outcomes and clinicopathologic differences of African‐American versus white patients treated with breast conservation therapy for early‐stage breast cancer (2008) (46)
Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history. (1998) (45)
Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. (2005) (45)
Intensity-Modulated Radiation Therapy for Rectal Carcinoma Can Reduce Treatment Breaks and Emergency Department Visits (2012) (45)
Conservative management of Paget disease of the breast with radiotherapy: 10- and 15-year results. (2002) (44)
The Yale University Experience of Early‐Stage Invasive Lobular Carcinoma (ILC) and Invasive Ductal Carcinoma (IDC) Treated with Breast Conservation Treatment (BCT): Analysis of Clinical‐Pathologic Features, Long‐Term Outcomes, and Molecular Expression of COX‐2, Bcl‐2, and p53 as a Function of Histol (2009) (44)
Intrafractional target motions and uncertainties of treatment setup reference systems in accelerated partial breast irradiation. (2011) (44)
The effect of advanced age on the efficacy of radiation therapy for early breast cancer, local prostate cancer and grade III-IV gliomas. (1993) (44)
β-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck (2005) (44)
Predictive factors of nipple involvement in breast cancer: a systematic review and meta-analysis (2015) (44)
Borderline ER‐Positive Primary Breast Cancer Gains No Significant Survival Benefit From Endocrine Therapy: A Systematic Review and Meta‐Analysis (2017) (44)
Radiotherapy in the treatment of hereditary breast cancer. (2011) (43)
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Brachytherapy Applicators Is Feasible and Safe: First Results From the TRIUMPH-T Trial. (2019) (43)
Prognostic significance of IGF-1R expression in patients treated with breast-conserving surgery and radiation therapy. (2010) (42)
Are Breast Cancer Subtypes Prognostic for Nodal Involvement and Associated with Clinicopathologic Features at Presentation in Early-Stage Breast Cancer? (2013) (42)
Impact of metformin use on survival in locally-advanced, inoperable non-small cell lung cancer treated with definitive chemoradiation. (2015) (42)
Prognostic value of triple-negative phenotype at the time of locally recurrent, conservatively treated breast cancer. (2008) (41)
ACR Appropriateness Criteria stage I breast cancer: initial workup and surveillance for local recurrence and distant metastases in asymptomatic women. (2014) (41)
Characteristics and spectrum of BRCA1 and BRCA2 mutations in 3,922 Korean patients with breast and ovarian cancer (2012) (41)
Correlates and Determinants of Nuclear Epidermal Growth Factor Receptor Content in an Oropharyngeal Cancer Tissue Microarray (2008) (41)
Linkage disequilibrium pattern of the ATM gene in breast cancer patients and controls; association of SNPs and haplotypes to radio-sensitivity and post-lumpectomy local recurrence (2007) (40)
DEAR1 Is a Dominant Regulator of Acinar Morphogenesis and an Independent Predictor of Local Recurrence-Free Survival in Early-Onset Breast Cancer (2009) (40)
Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy (2000) (40)
Riluzole Enhances Ionizing Radiation–Induced Cytotoxicity in Human Melanoma Cells that Ectopically Express Metabotropic Glutamate Receptor 1 In Vitro and In Vivo (2011) (40)
Prognostic significance of vascular endothelial growth factor protein levels in T1‐2 N0 laryngeal cancer treated with primary radiation therapy (2007) (40)
NRG Oncology-Radiation Therapy Oncology Group Study 1014: 1-Year Toxicity Report From a Phase 2 Study of Repeat Breast-Preserving Surgery and 3-Dimensional Conformal Partial-Breast Reirradiation for In-Breast Recurrence. (2017) (40)
Bcl-2 expression predicts local relapse for early-stage breast cancer receiving conserving surgery and radiotherapy (2009) (39)
Effectiveness of Breast-Conserving Surgery and 3-Dimensional Conformal Partial Breast Reirradiation for Recurrence of Breast Cancer in the Ipsilateral Breast: The NRG Oncology/RTOG 1014 Phase 2 Clinical Trial. (2019) (39)
Challenges Faced by Medical Journals During the COVID-19 Pandemic. (2020) (39)
Radiosensitization of Primary Human Glioblastoma Stem-like Cells with Low-Dose AKT Inhibition (2015) (39)
Post-Mastectomy Radiotherapy for Breast Cancer Patients with T1-T2 and 1-3 Positive Lymph Nodes: a Meta-Analysis (2013) (39)
Factors Associated with Optimal Cosmetic Results at 36 Months in Patients Treated with Accelerated Partial Breast Irradiation (APBI) on the American Society of Breast Surgeons (ASBrS) MammoSite® Breast Brachytherapy Registry Trial (2009) (39)
BCL-2 (-938C > A) polymorphism is associated with breast cancer susceptibility (2011) (39)
Milestones in the use of combined-modality radiation therapy and chemotherapy. (2014) (38)
Correlation of clinical and pathologic features with outcome in patients with ductal carcinoma in situ of the breast treated with breast-conserving surgery and radiotherapy. (2001) (38)
A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. (2009) (38)
Identification of the DNA Repair Defects in a Case of Dubowitz Syndrome (2013) (38)
Bioreductive alkylating agent porfiromycin in combination with radiation therapy for the management of squamous cell carcinoma of the head and neck. (1997) (38)
Radiation therapy for ductal carcinoma in situ of the breast. (1990) (38)
Treatment Techniques to Reduce Cardiac Irradiation for Breast Cancer Patients Treated with Breast-Conserving Surgery and Radiation Therapy: A Review (2014) (38)
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administration (2019) (37)
Adjuvant systemic chemotherapy and hormonal therapy. Effect on local recurrence in the conservatively treated breast cancer patient (1994) (37)
Prognostic significance of cyclin D1 protein levels in early‐stage larynx cancer treated with primary radiation (2000) (37)
Identification of Novel Variants of Metadherin in Breast Cancer (2011) (36)
Clinical-pathologic features and long-term outcomes of tubular carcinoma of the breast compared with invasive ductal carcinoma treated with breast conservation therapy. (2009) (36)
The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial (2018) (35)
Mammographic features are associated with clinicopathological characteristics in invasive breast cancer. (2011) (35)
Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: results of a randomized clinical trial. (1999) (35)
Object-constrained meshless deformable algorithm for high speed 3D nonrigid registration between CT and CBCT. (2009) (35)
Immunocytochemical analysis of breast cells obtained by ductal lavage (2002) (35)
Testin is a tumor suppressor and prognostic marker in breast cancer (2012) (34)
Patterns of reduced nipple aspirate fluid production and ductal lavage cellularity in women at high risk for breast cancer (2005) (34)
Estrogen-dependent prognostic significance of cyclooxygenase-2 expression in early-stage invasive breast cancers treated with breast-conserving surgery and radiation. (2008) (34)
Low p53 binding protein 1 (53BP1) expression is associated with increased local recurrence in breast cancer patients treated with breast-conserving surgery and radiotherapy. (2012) (34)
Postmastectomy radiotherapy. American College of Radiology. ACR Appropriateness Criteria. (2000) (33)
Has the Time Come to Stop Surgical Staging of the Axilla for All Women Age 70 Years or Older with Hormone Receptor-Positive Breast Cancer? (2017) (33)
Insurance Approval for Proton Beam Therapy and its Impact on Delays in Treatment. (2019) (33)
Timing of Chemotherapy after MammoSite radiation therapy system breast brachytherapy: analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. (2008) (33)
Molecular Markers in Head and Neck Squamous Cell Carcinoma: Their Biological Function and Prognostic Significance (2001) (33)
Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation. (2000) (33)
Long-term assessment of cardiac function after dose-dense and -intense sequential doxorubicin (A), paclitaxel (T), and cyclophosphamide (C) as adjuvant therapy for high risk breast cancer (2007) (33)
Use of postmastectomy radiotherapy in older women. (2008) (33)
The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation (2008) (33)
Quality measures, standards, and accreditation for breast centers in the United States. (2010) (32)
Subareolar breast cancer: long-term results with conservative surgery and radiation therapy. (1995) (32)
Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance). (2016) (32)
Parkin ubiquitinates phosphoglycerate dehydrogenase to suppress serine synthesis and tumor progression. (2020) (32)
Tissue Microarray Analysis Reveals Prognostic Significance of COX‐2 Expression for Local Relapse in T1–2N0 Larynx Cancer Treated with Primary Radiation Therapy (2004) (31)
Molecular and genetic markers in the local-regional management of breast cancer. (2002) (31)
Immunohistochemical Biomarkers in Patients with Early‐Onset Breast Carcinoma by Tissue Microarray (2005) (31)
Evaluation of Local Recurrence and Second Malignancy in Patients with T1 and T2 Squamous Cell Carcinoma of the Larynx (2004) (31)
Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient? (2008) (31)
Comparison of radiation‐induced fatigue across 3 different radiotherapeutic methods for early stage breast cancer (2011) (30)
Local control, toxicity, and cosmesis in women >70 years enrolled in the American Society of Breast Surgeons accelerated partial breast irradiation registry trial. (2012) (30)
American College of Radiology appropriateness criteria on conservative surgery and radiation: stages I and II breast carcinoma. (2008) (30)
Attracting Future Radiation Oncologists: An Analysis of the National Resident Matching Program Data Trends From 2004 to 2015. (2015) (30)
Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ. (2005) (30)
ACR Appropriateness Criteria® Conservative surgery and Radiation – Stage I and II Breast Carcinoma (2011) (30)
Mammographic findings of recurrent breast cancer after lumpectomy and radiation therapy: comparison with the primary tumor. (1996) (29)
Concurrent chemoradiation in the treatment of head and neck cancer. (1999) (29)
Ductal carcinoma in situ treated with breast‐conserving surgery and accelerated partial breast irradiation (2011) (29)
Evaluation of the National Resident Matching Program (NRMP) radiation oncology data (1993-2003). (2003) (28)
Chest Wall Relapse After Mastectomy for Ductal Carcinoma In Situ: A Report of 10 Cases with a Review of the Literature (2006) (28)
Handbook of radiation oncology : basic principles and clinical protocols (2009) (28)
Radiation techniques and toxicities for locally advanced breast cancer. (2009) (28)
Disruption of GRM1‐mediated signalling using riluzole results in DNA damage in melanoma cells (2014) (27)
Ionizing Radiation Sensitizes Breast Cancer Cells to Bcl-2 Inhibitor, ABT-737, through Regulating Mcl-1 (2014) (27)
End results of salvage therapy after failure of breast-conservation surgery. (2004) (27)
Dosimetric Feasibility and Acute Toxicity in a Prospective Trial of Ultrashort-Course Accelerated Partial Breast Irradiation (APBI) Using a Multi-Lumen Balloon Brachytherapy Device (2013) (27)
Tumor Bed Control with Balloon-Based Accelerated Partial Breast Irradiation: Incidence of True Recurrences Versus Elsewhere Failures in the American Society of Breast Surgery MammoSite® Registry Trial (2012) (26)
Fulvestrant treatment alters MDM2 protein turnover and sensitivity of human breast carcinoma cells to chemotherapeutic drugs (2014) (26)
Local Control, Toxicity, and Cosmesis in Women Younger Than 50 Enrolled Onto the American Society of Breast Surgeons MammoSite Radiation Therapy System Registry Trial (2009) (26)
The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy. (2015) (25)
Evaluation of acute locoregional toxicity in patients with breast cancer treated with adjuvant radiotherapy in combination with bevacizumab. (2011) (25)
beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck. (2005) (25)
Long-term outcome in patients with four or more positive lymph nodes treated with conservative surgery and radiation therapy. (1996) (24)
Radiation of the Internal Mammary Nodes: Is There a Benefit? (2016) (23)
Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy. (2004) (23)
Impact of Radiation on Locoregional Control in Women with Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy and Axillary Lymph Node Dissection: Results from ACOSOG Z1071 Clinical Trial. (2019) (23)
Mediator of DNA damage checkpoint protein 1 (MDC1) expression as a prognostic marker for nodal recurrence in early-stage breast cancer patients treated with breast-conserving surgery and radiation therapy (2011) (23)
Concurrent chemo-radiation in the conservative management of breast cancer. (2006) (23)
VX-984 is a selective inhibitor of non-homologous end joining, with possible preferential activity in transformed cells (2018) (23)
Conservative management of breast cancer in BRCA1/2 mutation carriers. (2004) (23)
Oncoplastic breast surgery in the setting of breast-conserving therapy: A systematic review (2016) (22)
Clinical Outcome and Cosmesis in African‐American Patients Treated with Conservative Surgery and Radiation Therapy (2003) (22)
BCCIP as a prognostic marker for radiotherapy of laryngeal cancer. (2009) (22)
Evaluation of Diabetic Patients with Breast Cancer Treated with Metformin during Adjuvant Radiotherapy (2013) (21)
Characteristics of double heterozygosity for BRCA1 and BRCA2 germline mutations in Korean breast cancer patients (2011) (21)
Nation-Scale Adoption of Shorter Breast Radiation Therapy Schedules Can Increase Survival in Resource Constrained Economies: Results From a Markov Chain Analysis. (2017) (21)
Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer. (2019) (21)
Hypofractionated radiation treatment in the management of breast cancer (2018) (21)
Adoption of intensity modulated radiation therapy for early-stage breast cancer from 2004 through 2011. (2015) (21)
Double Heterozygotes for Non‐Caucasian Families with Mutations in BRCA‐1 and BRCA‐2 Genes (2006) (21)
Proton Therapy for Breast Cancer: A Consensus Statement from the Particle Therapy Cooperative Group (PTCOG) Breast Cancer Subcommittee. (2021) (21)
Radiation oncology career decision variables for graduating trainees seeking positions in 2003-2004. (2005) (21)
Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: long-term tumor control and complications. (1999) (20)
Breast conservation therapy in patients with mammographically undetected breast cancer. (1992) (20)
Postoperative Concurrent Chemoradiotherapy with Mitomycin in Advanced Squamous Cell Carcinoma of the Head and Neck: Results from Three Prospective Randomized Trials (2006) (20)
Prognosis for mammographically occult, early-stage breast cancer patients treated with breast-conservation therapy. (2010) (20)
The Proapoptotic Molecule BLID Interacts with Bcl-XL and Its Downregulation in Breast Cancer Correlates with Poor Disease-Free and Overall Survival (2010) (20)
Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial. (2016) (20)
Breast-conservation Therapy After Neoadjuvant Chemotherapy Does Not Compromise 10-Year Breast Cancer–specific Mortality (2018) (20)
ACR Appropriateness Criteria® Ductal Carcinoma in Situ (2012) (19)
Use of combination proteomic analysis to demonstrate molecular similarity of head and neck squamous cell carcinoma arising from different subsites. (2009) (19)
Conservatively Treated Breast Cancer: Outcome by Histologic Subtype (1997) (19)
Radiosensitization effect of Huaier on breast cancer cells. (2016) (19)
Trends in active surveillance for very low‐risk prostate cancer: do guidelines influence modern practice? (2017) (19)
Factors associated with optimal long-term cosmetic results in patients treated with accelerated partial breast irradiation using balloon-based brachytherapy. (2012) (18)
A profile of academic training program directors and chairs in radiation oncology. (2013) (18)
Riluzole is a radio‐sensitizing agent in an in vivo model of brain metastasis derived from GRM1 expressing human melanoma cells (2015) (18)
Interferon‐Induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1‐2 N0 Breast Cancer Treated with Breast‐Conserving Surgery and Radiation Therapy (BCS + RT) (2013) (18)
BRCA1/2 germline mutations: a marker for radioresistance or radiosensitivity? (2000) (17)
ACR Appropriateness Criteria® Locally Advanced Breast Cancer (2011) (17)
Ultrashort courses of adjuvant breast radiotherapy (2012) (17)
Sudden death in aortic stenosis monitored by ear densitographic pulse and ECG. (1982) (17)
First-inHuman Clinical Trial of Oral ONC 201 in Patients with Refractory Solid Tumors (2019) (17)
Fulvestrant radiosensitizes human estrogen receptor-positive breast cancer cells. (2013) (17)
Radiotherapy as a New Player in Immuno-Oncology (2018) (17)
NRG Oncology/RTOG 1014: 3 Year Efficacy Report From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal Partial Breast Re-Irradiation (PBrI) for In-Breast Recurrence (2015) (17)
Molecular predictors of locoregional recurrence in breast cancer: ready for prime time? (2010) (17)
Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient (1992) (16)
DEAD box 1 (DDX1) expression predicts for local control and overall survival in early stage, node‐negative breast cancer (2012) (16)
The glutamate release inhibitor riluzole increases DNA damage and enhances cytotoxicity in human glioma cells, in vitro and in vivo (2019) (16)
5-year Update of a Multi Institution Prospective Phase II Hypofractionated Post-Mastectomy Radiation Therapy Trial. (2020) (16)
Association between cytosolic expression of BRCA1 and metastatic risk in breast cancer (2015) (16)
ACR Appropriateness Criteria® Ductal Carcinoma in Situ. (2015) (16)
BRCA Status, Molecular Markers, and Clinical Variables in Early, Conservatively Managed Breast Cancer (2003) (16)
Malignant biliary obstruction: intracavitary treatment with a high-dose-rate remote afterloading device. (1987) (16)
Clinicopathologic significance of excision repair cross-complementation 1 expression in patients treated with breast-conserving surgery and radiation therapy. (2010) (15)
Current application and research directions for partial-breast irradiation. (2007) (15)
Is breast-conserving therapy in the genetically predisposed breast cancer patient a reasonable and appropriate option? (2004) (15)
Close to Home: Employment Outcomes for Recent Radiation Oncology Graduates. (2016) (15)
Setup uncertainties and the optimal imaging schedule in the prone position whole breast radiotherapy (2019) (14)
Outcome after ipsilateral breast tumor recurrence in patients who receive accelerated partial breast irradiation (2012) (14)
A 3D global-to-local deformable mesh model based registration and anatomy-constrained segmentation method for image guided prostate radiotherapy. (2010) (14)
Evaluation of single nucleotide polymorphisms (SNPs) in the p53 binding protein 1 (TP53BP1) gene in breast cancer patients treated with breast-conserving surgery and whole-breast irradiation (BCS + RT). (2009) (14)
Prognostic significance of calcium-sensing receptor in breast cancer (2014) (14)
Cardiac responses during uninterrupted treadmill exercise and recovery. Measurement by systolic time intervals (1978) (14)
Hypofractionated breast radiation: preferred standard of care? (2013) (14)
Improved treatment of pelvis and inguinal nodes using modified segmental boost technique: dosimetric evaluation. (2002) (14)
American Board of Radiology Maintenance of Certification - Part IV: practice quality improvement for radiation oncology. (2007) (14)
National Residency Matching Program results for radiation oncology, 2005 update. (2005) (13)
National Residency Matching Program (NRMP) results for radiation oncology, 2004 update. (2004) (13)
Radiation therapy and the risk of contralateral breast cancer. (2003) (13)
The Impact of Formal Mentorship Programs on Mentorship Experience Among Radiation Oncology Residents From the Northeast (2019) (13)
Dose-Painted Intensity Modulated Radiation Therapy Improves Local Control for Locally Advanced Pancreas Cancer (2012) (13)
Evaluation of Acute Locoregional Toxicity in Patients with Breast Cancer Treated with Adjuvant Radiotherapy in Combination with Pazopanib (2012) (13)
Is Ki-67 expression prognostic for local relapse in early-stage breast cancer patients treated with breast conservation therapy (BCT)? (2013) (13)
Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? (2007) (13)
Frequency filtering based analysis on the cardiac induced lung tumor motion and its impact on the radiotherapy management. (2014) (13)
Hypofractionation in adjuvant breast radiotherapy. (2010) (13)
Noninvasive assessment of left ventricular performance in patients with ischemic heart disease: ear densitographic study during uninterrupted treadmill exercise. (1981) (13)
LIF is essential for ISC function and protects against radiation-induced gastrointestinal syndrome (2020) (12)
National Residency Matching Program results for radiation oncology: 2006 update. (2006) (12)
ACR Appropriateness Criteria Palpable Breast Masses. (2016) (12)
ACR Appropriateness Criteria® Local-regional Recurrence (LR) and Salvage Surgery: Breast Cancer (2012) (12)
Imaging opportunities in radiation oncology. (2011) (12)
Early vs. delayed radiotherapy in a small cohort of patients with supratentorial low grade glioma (1997) (12)
External-beam accelerated partial-breast irradiation: exploring the limits of tolerability. (2013) (12)
Prognostic significance of mammographic detection in a cohort of conservatively treated breast cancer patients. (1998) (12)
Factors that determine academic versus private practice career interest in radiation oncology residents in the United States: results of a nationwide survey. (2013) (12)
Can lung cancer be cured by irradiation alone? (1992) (12)
Prognostic Significance of p 16 Protein Levels in Oropharyngeal Squamous Cell Cancer (2004) (12)
Motion and volumetric change as demonstrated by 4DCT: The effects of abdominal compression on the GTV, lungs, and heart in lung cancer patients. (2016) (11)
Does Compliance with Radiation Therapy Differ in African‐American Patients with Early‐Stage Breast Cancer? 1 (2010) (11)
Mammographically detected breast cancer. Results with conservative surgery and radiation therapy (1991) (11)
Advantage of PET/CT in Target Delineation of MRI-negative Cervical Lymph Nodes In Intensity-Modulated Radiation Therapy Planning for Nasopharyngeal Carcinoma (2017) (11)
Short‐term and long‐term clinical outcomes of uncommon types of invasive breast cancer (2017) (11)
National Residency Matching Program (NRMP) results for radiation oncology: 2007 update. (2007) (11)
A Clinical Evaluation of Thoracic Electrical Impedance (1977) (11)
Responses of peak ear-pulse derivative to changing left ventricular function. (1980) (11)
Is breast-conserving surgery with radiation superior to mastectomy in selected patients? (1997) (11)
PALB2 mutations 1592delT and 229delT are not present in Korean breast cancer patients negative for BRCA1 and BRCA2 mutations (2010) (11)
Axillary Failure in Patients Treated with MammoSite Accelerated Partial Breast Irradiation (2011) (11)
Radiation recall 5 years after whole-breast irradiation for early-stage breast cancer secondary to initiation of rosuvastatin and amlodipine. (2011) (11)
Conservative surgery and radiation in the treatment of stage I and II carcinoma of the breast. American College of Radiology. ACR Appropriateness Criteria. (2000) (11)
Molecular subtyping of early-stage breast cancer: implications for radiation therapy. (2010) (10)
The Location of Contralateral Breast Cancers After Radiation Therapy (2001) (10)
Prognostic value of DNA flow cytometry in the locally recurrent, conservatively treated breast cancer patient. (1992) (10)
Three-year outcomes of a once daily fractionation scheme for accelerated partial breast irradiation (APBI) using 3-D conformal radiotherapy (3D-CRT) (2013) (10)
Role of excision repair cross‐complementation 1 expression as a prognostic marker for response to radiotherapy in early‐stage laryngeal cancer (2013) (10)
Patterns of intrafractional motion and uncertainties of treatment setup reference systems in accelerated partial breast irradiation for right- and left-sided breast cancer. (2014) (10)
Alternatives to Standard Fractionation Radiation Therapy After Lumpectomy: Hypofractionated Whole-Breast Irradiation and Accelerated Partial-Breast Irradiation. (2018) (9)
Prevalence of Surface Contamination With SARS-CoV-2 in a Radiation Oncology Clinic. (2020) (9)
On the assay of brachytherapy sources. (2007) (9)
Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neck: Results of a phase I clinical trial (1993) (9)
National Residency Matching Program (NRMP) results for radiation oncology: 2011 update. (2012) (9)
Breast conserving therapy in breast cancer patients presenting with nipple discharge. (2000) (9)
Patterns of Failure in Colorectal Patients With Liver Metastases After Yttrium-90 Radioembolization (2014) (9)
Tracking the dynamic seroma cavity using fiducial markers in patients treated with accelerated partial breast irradiation using 3D conformal radiotherapy. (2013) (9)
The Evolution of Regional Nodal Irradiation in Breast Cancer (2015) (9)
Rate of rise of the carotid pulse. An investigation of observer error in a common clinical measurement. (1982) (9)
Has Placement of Surgical Clips in the Lumpectomy Bed Fallen Out of Favor? (2011) (9)
Abstract P5-14-19: Radiation field design on the ACOSOG Z0011 trial (2013) (9)
Radiation oncology, resident research, and the American Board of Radiology Holman Pathway. (2005) (9)
Optimization of couch translational corrections to compensate for rotational and deformable target deviations in image guided radiotherapy. (2008) (9)
Recurrence and Survival in the American Society of Breast Surgeons (ASBS) MammoSite ® RTS Registry Trial (2008) (8)
Lumpectomy Closure Technique Does Not Affect Dosimetry in Patients Undergoing External-Beam-Based Accelerated Partial Breast Irradiation (2013) (8)
Phosphorylation of Akt ( Ser 473 ) Predicts Poor Clinical Outcome in Oropharyngeal Squamous Cell Cancer (2007) (8)
The impact of skin-sparing mastectomy with immediate reconstruction in patients with stage III breast cancer treated with neoadjuvant chemotherapy and postmastectomy radiation (2012) (8)
Five-Year Results of a Prospective Phase 2 Trial Evaluating Three-Week Hypofractionated Whole Breast Radiotherapy Inclusive of a Sequential Boost. (2019) (8)
Utilization of Breast Conserving Therapy in Stages 0, I, and II Breast Cancer Patients in New Jersey: An American College of Surgeons National Cancer Data Base (NCDB) Analysis (2012) (8)
Cullin 3 – KLHL 25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression (2016) (8)
Evaluation of vascular endothelial growth factor as a prognostic marker for local relapse in early-stage breast cancer patients treated with breast-conserving therapy. (2011) (8)
Five-Year Update of an Expanded Phase II Study of Dose-Dense and -Intense Doxorubicin, Paclitaxel and Cyclophosphamide (ATC) in High-Risk Breast Cancer (2005) (8)
Using respiratory motion to guide planning target volume margins for external beam partial breast irradiation. (2012) (8)
Roles of BCCIP deficiency in mammary tumorigenesis (2017) (8)
Supine or Prone Breast Radiation: Upsides and Downsides. (2018) (7)
Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting. (1999) (7)
Tracking left ventricular performance noninvasively. Response of the peak ear pulse derivative during cardiac catheterization. (1983) (7)
Hypofractionated whole breast irradiation is cost-effective-but is that enough to change practice? (2018) (7)
Genetic anticipation of familial breast cancer with or without BRCA mutation in the Korean population. (2014) (7)
National residency matching program (NRMP) results for radiation oncology: 2010 update. (2011) (7)
Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 Study (2020) (7)
Development of an ambulatory systolic time interval monitoring system. (1977) (7)
Comparison of Mammographic Changes Across Three Different Fractionation Schedules for Early-Stage Breast Cancer. (2016) (7)
Special subtypes with favorable prognosis in breast cancer: A registry-based cohort study and network meta-analysis. (2020) (7)
Intraductal carcinoma of the breast: Long-term results with breast-conserving surgery and definitive irradiation (1993) (7)
Low Risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery & Accelerated Partial Breast Irradation (APBI): Comparison of the Mammosite Registry Trial with Intergroup Study E5194. (2009) (7)
Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer. (2015) (7)
COX-2 expression in post-mastectomy chest wall relapse (2005) (7)
Need for Competency-Based Radiation Oncology Education in Developing Countries (2017) (7)
Improvement in dose homogeneity with electronic tissue compensation over IMRT and conventional RT in whole brain radiotherapy. (2008) (7)
Imrt of whole pelvis and inguinal nodes: Evaluation of dose distributions produced by an inverse treatment planning system (2004) (7)
Parameterization of brachytherapy source phase space file for Monte Carlo-based clinical brachytherapy dose calculation (2014) (7)
Erythrityl Tetranitrate Compared with Isosorbide Dinitrate: Effects on Systolic Time Intervals and Nitrate Modification of Effects of Food (1983) (7)
Breast-conserving treatment in the elderly: long-term results of adjuvant hypofractionated and normofractionated radiotherapy (2010) (7)
Three-dimensional dosimetric considerations from different point A definitions in cervical cancer low-dose-rate brachytherapy (2013) (7)
Genetic Factors in the Locoregional Management of Breast Cancer. (2020) (6)
Outcomes following breast conservation versus mastectomy in BRCA1/2 carriers with early-stage breast cancer (2008) (6)
Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes? (2013) (6)
Hypofractionated Postmastectomy Radiation Therapy (2020) (6)
Management of suspicious or indeterminate calcifications and impact on local control (2005) (6)
ACR Appropriateness Criteria® Stage I Breast Carcinoma. (2016) (6)
Tagged MRI Based Cardiac Motion Modeling and Toxicity Evaluation in Breast Cancer Radiotherapy (2015) (6)
Severe Gastrointestinal Mucositis Following Concurrent Palbociclib and Palliative Radiation Therapy (2020) (6)
Exposure to diagnostic levels of radiation prior to age 30 increases the risk of breast cancer in BRCA1/2 carriers (2012) (6)
Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations (2020) (6)
First-in-human dose escalation study of oral ONC201 in advanced solid tumors. (2015) (6)
Radiation oncology: a snapshot in time, 2014. (2014) (6)
Multi-institutional experience of ductal carcinoma in situ in black vs white patients treated with breast-conserving surgery and whole breast radiation therapy. (2012) (6)
Individualized Prediction of Survival Benefit from Postmastectomy Radiotherapy for Patients with Breast Cancer with One to Three Positive Axillary Lymph Nodes. (2019) (6)
Cardiac responses to impulse exercise and recovery: systolic time intervals. (1979) (6)
Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer (2020) (6)
The Relative Benefits of Tamoxifen in Older Women with T1 Early‐Stage Breast Cancer Treated with Breast‐Conserving Surgery and Radiation Therapy (2013) (6)
National residency matching program results for radiation oncology: 2012 update. (2013) (6)
Accelerated Partial Breast Irradiation: Where Do We Go from Here? (2005) (6)
Is There a Role for Postmastectomy Radiation (PMRT) in Patients with T1–2 Tumors and One to Three Positive Lymph Nodes Treated in the Modern Era? (2018) (5)
Prognosis for Survival of Young Women with Breast Cancer by Quantitative p53 Immunohistochemistry. (2012) (5)
ACR Appropriateness Criteria local-regional recurrence (LRR) and salvage surgery-breast cancer. (2014) (5)
Issues in the curative therapy of breast cancer in elderly women. (2012) (5)
Objected constrained registration and manifold learning: a new patient setup approach in image guided radiation therapy of thoracic cancer. (2013) (5)
Regional Nodal Irradiation in Breast Cancer (2016) (5)
Bioavailability of Organic Nitrates: A Comparison of Methods for Evaluating Plethysmographic Responses (1982) (5)
Optimization of surgical clip placement for breast-conservation therapy. (2014) (5)
Predictive parameters for selection of electronic tissue compensation radiotherapy in early-stage breast cancer patients after breast-conserving surgery (2016) (5)
Interferon-induced Protein with Tetratricopeptide Repeats 1 (IFIT1) as a Prognostic Marker for Local Control in T1-2 N0 Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT) (2011) (5)
The radiation oncology milestone project. (2014) (5)
No benefit to intentionally targeting the internal mammary lymph nodes in conservatively managed breast cancer patients (1998) (5)
Noninvasive tracking of peripheral resistance by ear densitography. (1983) (5)
Three-Fraction TRIUMPH-T Brachytherapy for Delivery of APBI Offers Effective Disease Control With Minimal Late Toxicity. (2021) (5)
ACR Appropriateness Criteria Stage I Breast Cancer: Initial Workup and Surveillance for Local Recurrence and Distant Metastases in Asymptomatic Women. (2016) (5)
BRCA1/BRCA2 in breast-conserving therapy. (1999) (5)
Basal Subtype, as Approximated by Triple-Negative Phenotype, is Associated with Locoregional Recurrence in a Case–Control Study of Women with 0–3 Positive Lymph Nodes After Mastectomy (2014) (5)
ACR Appropriateness Criteria® stage I breast carcinoma. (2012) (5)
2006 : Two Year Actuarial Analysis of 198 Patients With DCIS Treated With Accelerated Partial Breast Irradiation (APBI): Efficacy, Cosmesis and Toxicity in Patients on the American Society of Breast Surgeons (ASBS) MammoSite Breast Brachytherapy Registry Trial (2006) (5)
Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials (2015) (5)
A phase II study evaluating the role of sentinel lymph node surgery and axillary lymph node dissection following preoperative chemotherapy in women with node-positive breast cancer (T1-4, N1-2, M0) at initial diagnosis: ACOSOG Z1071. (2010) (4)
Has Placement of Surgical Clips in the Lumpectomy Bed Fallen Out of Favor? (2011) (4)
Metabolic enzyme LDHA activates Rac1 GTPase as a noncanonical mechanism to promote cancer (2022) (4)
Ultra-short courses of adjuvant breast radiotherapy: promised land or primrose path? (2012) (4)
A Statewide Multi-Institutional Study of Asymptomatic Pretreatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States (2021) (4)
Ductal carcinoma in situ and microinvasive disease. American College of Radiology. ACR Appropriateness Criteria. (2000) (4)
Role of Excision Repair Cross Complementation 1 Expression as a Prognostic Marker for Response to Radiotherapy in Early Stage Laryngeal Cancer (2010) (4)
Redox Protein Expression Predicts Radiotherapeutic Response in Early-Stage Invasive Breast Cancer Patients (2011) (4)
2101 Post-operative high dose rate vaginal apex brachytherapy in stage I endometrial adenocarcinoma (1996) (4)
Diastolic time during recovery from upright exercise in persons without heart disease. (1985) (4)
Cost-Effectiveness of Adjuvant Treatment for Ductal Carcinoma In Situ (2021) (4)
Impact of Radiation on Local Regional Control in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy (NAC) and Axillary Lymph Node Dissection (ALND); Results From ACOSOG Z1071 (Alliance) (2016) (4)
Proton versus Photon Breath-Hold Radiation for Left-Sided Breast Cancer after Breast-Conserving Surgery: A Dosimetric Comparison (2019) (4)
Handbook Of Radiation Oncology (2008) (4)
SARS‐CoV‐2 nosocomial infection: Real‐world results of environmental surface testing from a large tertiary cancer center (2021) (4)
Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients (2019) (4)
Clinicopathologic Presentation of Asian-Indian American (AIA) Women with Stage 0, I & II Breast Cancer (2011) (4)
Local Therapy in BRCA1/2 Carriers with Operable Breast Cancer: Comparison of Breast Conservation and Mastectomy. (2009) (4)
Intraoperative brachytherapy, laryngopharyngoesophagectomy, and gastric transposition for patients with recurrent hypopharyngeal and cervical esophageal carcinoma (1998) (4)
Dose Perturbations of Gold Fiducial Markers in the Prostate Cancer Intensity Modulated Proton Radiation Therapy (IMPT) (2012) (4)
Placement and Visualization of Surgical Clips in the Lumpectomy Cavity of Patients with Stage 0, I, and II Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (BCS+RT) (2010) (3)
A strategy to objectively evaluate the necessity of correcting detected target deviations in image guided radiotherapy. (2007) (3)
Cardiac response during uninterrupted treadmill exercise and recovery: measurement by systolic time intervals. (1978) (3)
Re: what do recent studies on lumpectomy cavity volume change imply for breast clinical target volumes? (2009) (3)
Registration of Lung Tissue Between Fluoroscope and CT Images: Determination of Beam Gating Parameters in Radiotherapy (2007) (3)
Who's on first? Sequencing chemotherapy and radiation therapy in conservatively managed node-negative breast cancer. (1999) (3)
Escaping death to quiescence (2013) (3)
A novel approach to Verify air gap and SSD for proton radiotherapy using surface imaging (2019) (3)
Locally advanced breast cancer. American College of Radiology. ACR Appropriateness Criteria. (2000) (3)
Evaluation of Single Nucleotide Polymorphisms (SNP) in the P53 Binding Protein Gene (TP53BP1), in Br (2009) (3)
Postmastectomy intensity modulated radiation therapy following immediate expander-implant reconstruction: Koutcher L, Ballangrud Å, Cordeiro PG, et al (Memorial Sloan-Kettering Cancer Ctr, NY) Radiother Oncol 94:319-323, 2010§ (2010) (3)
Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients (2019) (3)
Mucinous (Colloid) Carcinoma of the Breast: Clinicopathologic Features & Long-term Outcomes of Women Treated with Breast-conserving Therapy (2009) (3)
A Clinical Objective IMRT QA Method Based on Portal Dosimetry and Electronic Portal Imager Device (EPID) Measurement (2013) (3)
Therapeutics , Targets , and Chemical Biology p 53-Dependent BRCA 1 Nuclear Export Controls Cellular Susceptibility to DNA Damage (2011) (3)
Incidence of Brain Metastases in Early-Stage Triple Negative Breast Cancer Patients (2007) (3)
The Impact of COVID-19 on Brachytherapy During the Pandemic: A Rutgers-Robert Wood Johnson Barnabas Health Multisite Experience (2020) (3)
Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic Features (2019) (3)
Poly(ADP-ribose) polymerase-1 (PARP-1) expression in patients treated with breast-conserving surgery and radiation therapy (BCS+RT). (2010) (3)
Using Nodal Ratios to Predict Risk of Regional Recurrences in Patients Treated with Breast Conservation Therapy with 4 or More Positive Lymph Nodes (2011) (3)
Radiation Boost for Ductal Carcinoma In Situ After Whole-Breast Radiation Therapy (WBRT) Improves Local Control: Analysis From 10 Pooled Academic Institutions (2016) (3)
A Laplacian Surface Deformation and Optimization Based 3D Registration Algorithm for Image Guided Prostate Radiotherapy (2012) (3)
Regional nodal management in the light of the AMAROS trial. (2015) (3)
Immunohistochemical biomarkers in patients with early-onset breast carcinoma by tissue microarray. (2004) (3)
Changing trends and disparities in 5-year overall survival of women with invasive breast cancer in the United States, 1975-2015. (2021) (3)
Clinical characteristics and dose-volume histogram parameters associated with the development of pleural effusions in non-small cell lung cancer patients treated with chemoradiation therapy (2016) (3)
Is the BRCA Germline Mutation a Prognostic Factor in Korean Patients with Early-onset Breast Carcinomas?. (2003) (3)
Elucidation of physiologic lengthening of left ventricular ejection time during early upright exercise. (1981) (3)
Is radiation therapy a viable alternative to surgery in early stage lung cancer? (1990) (3)
Vascular Endothelial Growth Factor as a Prognostic Marker for Local Relapse in Early-stage Breast Cancer Patients Treated with Breast Conservation Therapy (2009) (3)
Sequential High‐Dose Alkylating Therapy and Stem Cell Support for High‐Risk Stage III Breast Cancer (2003) (3)
Radiation Therapy and Talimogene Laherparepvec (TVEC) Synergize in the Treatment of Melanoma (2017) (3)
Is Axillary Radiation not Inferior to Axillary Dissection for Sentinel Lymph Node-Positive Breast Cancer After Neoadjuvant Chemotherapy? (2021) (2)
Optimization of Heart Block in the Left-Sided Whole Breast Radiation Treatments (2014) (2)
Efficacy of fiducial marker-based image-guided radiation therapy in prostate tomotherapy and potential dose coverage improvement using a patient positioning optimization method. (2012) (2)
First-in-human trial of ONC201 in patients with refractory solid tumors. (2016) (2)
Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States (2021) (2)
CONSENSUS STATEMENT: APBI FROM ASTRO (2010) (2)
Early Results of a Novel Hypofractionated Schedule for Adjuvant Radiation Therapy in Early-stage Breast Cancer (2011) (2)
Expert Consultations in Breast Cancer: Critical Pathways and Clinical Decision Making (2000) (2)
Watchful Waiting-Active Surveillance in Low-Risk Prostate Cancer. (2015) (2)
The evolution of adjuvant radiation therapy for early‐stage and locally advanced breast cancer (2019) (2)
Noninvasive ambulatory monitoring of physiologic data: recording systolic time intervals. (1978) (2)
Association Between Tumor Molecular Subtype and Disease Presentation in Patients With Early-stage Breast Cancer (2012) (2)
Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings (2020) (2)
Basal Subtype, as Approximated by Triple Negative Phenotype, is Associated With Locoregional Recurrence in a Case-control Study of Women With 0-3 Positive Lymph Nodes After Mastectomy (2012) (2)
1058 Bilateral breast carcinoma: Results with breast conservation therapy and a comparison with bilateral mastectomy (1996) (2)
Correlates and determinants of nuclear epidermal growth factor receptor (EGFR) content in an oropharyngeal cancer tissue microarray (2007) (2)
Radiation Use and Field Design in Women With Node Positive Breast Cancer Treated With Preoperative Systemic Therapy and Breast Surgery Including Axillary Dissection on a Prospective Clinical Trial ACOSOG Z1071 [Alliance] (2015) (2)
Oropharyngeal squamous cell cancers (OSCC) bearing transcriptionally active human papillomavirus (HPV) display distinct protein expression profile. (2006) (2)
A systematic approach to statistical analysis in dosimetry and patient-specific IMRT plan verification measurements (2013) (2)
Salvage treatment for local recurrence after breast-conserving surgery followed by radiation as initial treatment for mammographically-detected ductal carcinoma in situ of the breast (2004) (2)
Salvage treatment for recurrence in the breast following breast-conserving surgery and definitive irradiation for ductal carcinoma in situ (intraductal carcinoma) of the breast (1993) (2)
Cyclooxygenase-2 Expression in Postmastectomy Chest Wall Relapse (2005) (2)
Left ventricular performance during exercise: response of ear densitogram derivative. (1983) (2)
Combined Radiation and Oncolytic Viral Therapy Augments Cytotoxic and Immunogenic Antitumor Effects Against Melanoma (2018) (2)
Advances in Radiotherapy for Breast Cancer (2010) (2)
Cardiovascular Toxicities of Breast Cancer Treatment: Emerging Issues in Cardio-Oncology (2015) (2)
Can molecular markers predict local, regional and distant metastasis in head and neck cancer? (2005) (2)
Oral Scientific SessionNRG Oncology/RTOG 1014: 1-Year Toxicity Report From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal Partial-Breast Reirradiation (PBrI) for In-Breast Recurrence (2015) (2)
"Paradoxical" reduction in postexercise ejection time and increased transthoracic impedance. (1978) (2)
18 Longterm follow-up inpatients with four or more positive lymph nodes treated with conservative surgery and radiation therapy (1995) (2)
Extrapolation of ACOSOG Z0011 trial results—A survey of breast cancer providers (2021) (2)
The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols. (2018) (2)
1023 Stereotactic radiosurgery for brain metastases (1997) (2)
SU-E-J-263: Dosimetric Analysis On Breast Brachytherapy Based On Deformable Image Registration. (2014) (2)
NRG Oncology/RTOG 1014: Patient Reported Outcomes (PRO) and Cosmesis From a Phase II Study of Repeat Breast Preserving Surgery and 3D Conformal (3D-CRT) Partial Breast Re-Irradiation (PBrI) for In-Breast Recurrence. (2018) (2)
Concurrent chemo-radiotherapy with mitomycinc (MC) compared to porfiromycin (PO) in squamous cell carcinoma of the head and neck (SCCHN): final results of a randomized clinical trial (2003) (2)
Clinical activity of ONC201 in metastatic castrate resistant prostate cancer (mCRPC). (2016) (1)
Elevated frequency of germline BRCA1/BRCA2 gene mutations in locally recurrent breast cancer patients following lumpectomy and radiation therapy: Implications for breast conserving management in affected patients (1998) (1)
Clinical activity of the selective DRD2 antagonist ONC201, an imipridone, in metastatic endometrial cancer (mEC). (2017) (1)
The American Society of Breast Surgery MammoSite Registry: Factors Associated with Optimal Long-term Cosmetic Results (2011) (1)
Cytosolic Mislocalization of BRCA1 Is Associated With Increased Metastatic Risk in Breast Cancer (2013) (1)
Using Size and Grade to Identify Women Aged ≥ 70 Years with Endocrine-Responsive Breast Cancer at Low Risk of Nodal Positivity (2017) (1)
Effect of the use of immediate reconstruction on the rates of bilateral mastectomy and adjuvant radiation therapy use in women with node-positive breast cancer treated with neoadjuvant chemotherapy on ACOSOG Z1071 (Alliance). (2015) (1)
Does the Use of BioZorb® Result in Smaller Breast Seroma Volume? (2022) (1)
46 Curative high dose rate vaginal apex brachytherapy in stage I papillary serous carcinoma of the endometrium (1996) (1)
Utilization of Hypofractionated Whole-Breast Radiotherapy With Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy. (2020) (1)
Analysis of epidermal growth factor receptor (EGFR) pathway in oropharyngeal squamous cell cancer patients in vivo (OSCC) (2005) (1)
Gene copy number of epidermal growth factor receptor (EGFR) by fluorescent in situ hybridization (FISH) in head and neck squamous cell carcinomas (HNSCC) is closely correlated with EGFR protein levels assessed by automated quantitative protein analysis (AQUA) (2007) (1)
Correction to: Nomogram-based estimate of axillary nodal involvement in ACOSOG Z0011 (Alliance): validation and association with radiation protocol variations (2020) (1)
Prognosis following local recurrence in conservatively treated breast cancer (1990) (1)
Axillary Dissection Versus No Axillary Dissection in Elderly Patients with Breast Cancer and No Palpable Axillary Nodes: Results After 15Years of Follow-Up (2011) (1)
Impact of Insurance Preauthorization Requirements on Delays in Administering Proton Beam Therapy (2018) (1)
Can Sporadic Breast Cancers with Genetically Wild-type BRCA1 Behave Phenotypically Like BRCA1-associated Breast Tumors? (2009) (1)
DDIS-16. ONC201 IN COMBINATION WITH RADIATION EXHIBITS SYNERGISTIC EFFICACY IN HIGH GRADE GLIOMAS AND OTHER ADVANCED CANCERS (2018) (1)
SU-E-T-469: Dosimetric Impact of Whole Breast Treatment Planning with Tissue Heterogeneity Correction (2013) (1)
TH-C-WAB-07: Optimization of Heart Block in the Left-Sided Whole Breast Irradiation. (2013) (1)
Differences between African American (AA) and Caucasian (C) Patients Treated With Conservative Surgery and Radiation Therapy (CS+RT) for Early Stage Breast Cancer (2007) (1)
Abstract 4406: Cullin3-KLHL25 ubiquitin ligase targets ACLY for degradation to inhibit lipid synthesis and tumor progression (2017) (1)
Predicted germline BRCA1/BRCA2 mutations and second primary ipsilateral breast cancers in young women with pure ductal carcinoma in-situ treated with breast conserving therapy (2000) (1)
SU-E-T-10: Monte Carlo Study of the Dose Enhancement Factor (DEF) for Gold Nano-Particle (GNP) on the Cellular Level. (2012) (1)
Breast Cancer Management in the Era of Molecular Medicine: Tailored Radiotherapy — Clinical and Biological Aspects (2006) (1)
Postoperative Interval Between Surgery and Initiation of Adjuvant Therapy Corresponds to Local Recurrence in Resected Pancreatic Cancer (2013) (1)
Frequency of the CHEK2 1100delC Mutation in Korean Women with Early Onset Breast Cancer (2008) (1)
Abstract P4-12-08: Evaluation of acute toxicity in triple negative breast cancer patients receiving concurrent capecitabine and radiation (2020) (1)
Characteristics of HER-2/neu Oncogene in Korean Women with Early-onset Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization (2003) (1)
Imipridone (ONC201) and Radiation Therapy Combination Shows Promise in Breast Cancer Treatment (2018) (1)
Prognostic Factors in Patients with Head and Neck Cancer 87 (1)
Breast cancer awareness among Afghan refugee women in Turkey (2022) (1)
Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy. (2022) (1)
Long-Term Results of Hypofractionated Radiation Therapy for Breast Cancer: Whelan TJ, Pignol J-P, Levine MN, et al (McMaster Univ, Hamilton, Ontario, Canada; Odette Cancer Centre, Toronto, Ontario, Canada; et al) N Engl J Med 362:513-520, 2010 § (2010) (1)
2178 Vascular endothelial growth factor protein levels are an independent predictor of poor outcome in oral cavity and oropharyngeal squamous cell carcinoma (1999) (1)
Prevention of Radiation Dermatitis in Breast Cancer Patients (2013) (1)
TH‐C‐201C‐05: A Laplacian Surface Deformation and Optimization Based 3D Registration Algorithm for Image Guided Prostate Radiotherapy (2010) (1)
Effects of riluzole (RZ) and ionizing radiation (IR) in metabotropic glutamate receptor-1 (GRM1) positive human melanoma. (2009) (1)
4–37 Breast cancer in patients carrying a germ-line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy (2008) (1)
Do PET and SNB reduce the rate of elective neck dissection? A hypothesis still in need of validation. (2005) (1)
Impact of Metformin Use on Survival in Non-Small Cell Lung Cancer Treated With Definitive Radiation Therapy (2014) (1)
Reply to “Can Patients with Multiple Breast Cancers in the Same Breast Avoid Mastectomy by Having Multiple Lumpectomies to Achieve Equivalent Rates of Local Breast Cancer Recurrence? Response to the Preliminary Alliance 11102 Trial Report” (2018) (1)
SU‐EE‐A3‐05: Real Time Tumor Motion Monitoring during IGRT Based on Manifold Learning and Dynamic Registration between 4DCT and Fluoroscopy (2010) (1)
Stereotactic Radiosurgery for Brain Metastases (1998) (1)
Factors Associated With Optimal Cosmetic Results at 60 Months in Patients Treated With Accelerated Partial Breast Irradiation on the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial (2011) (1)
Radiotherapy: Hypofractionation for breast cancer—clinical implications (2010) (1)
Utilization of Hypofractionated Whole-Breast Radiotherapy with Concurrent Anti-Human Epidermal Growth Factor Receptor 2 (HER2) Therapy (2019) (1)
A systematic approach to statistical analysis in dosimetry and patient-specific IMRT plan verification measurements (2012) (1)
Assessing Clinical Competence in Radiation Oncology Education (2012) (1)
P7 The CHEK2 1100delC mutation is not present in Korean patients with breast cancer tested for BRCA1 and BRCA2 mutation (2007) (1)
Abstract 81: Role of GRM1 in breast cancer (2012) (1)
Author response: Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis (2015) (1)
Management of early-onset breast cancer and BRCA1 or BRCA2 status (2002) (1)
113 The use of radiotherapy in the conservative management of pager's disease (1996) (1)
Utilization of Radiation Therapy and Predictors of Noncompliance among Syrian Refugees with Cancer Living in Turkey (2020) (1)
7N Local therapy options in BRCA1/2 carriers with operable breast cancer: the importance of adjuvant chemotherapy (2010) (1)
156 Cyclin D1 expression mediates sensitivity in ataxia telangiectasia and breast cancer (1999) (1)
Correlations between BRCA status, molecular markers and clinical variables in early onset conservatively managed breast cancer (2001) (1)
Impact of radiation on local regional control in women with node positive breast cancer treated with neoadjuvant chemotherapy and axillary lymph node dissection: Results from ACOSOG 1071 Clinical Trial (2019) (1)
Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey (2022) (1)
Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients. (2017) (1)
A Statewide Multi-institutional Study of Asymptomatic Pre-Treatment Testing of Radiation Therapy Patients for SARS-CoV-2 in a High-Incidence Region of the United States (2020) (1)
1 The regulation of ipsilateral breast tumor recurrence after lumpectomy and radiation therapy by the transcription factors p53 and AP2 (1997) (1)
Concurrent chemo-radiotherapy in operable breast cancer (2006) (1)
Using Nodal Ratios to Predict the Risk of In-Field Regional Recurrences in Patients Treated With Breast Conservation Therapy in Patients With 4 or More Positive Lymph Nodes (2007) (1)
Abstract P1-15-25: Phase II trial of hypofractionated post mastectomy radiation (2015) (1)
Combination Radiation Therapy and Imipridone ONC201 for the Treatment of Solid Tumors (2017) (1)
Local-regional relapse and distant metastasis in conservatively managed triple negative early stage breast cancer. (2006) (1)
Concurrent Chemo-Radiotherapy in Conservatively Managed Early Stage Breast Cancer (2005) (1)
Local regional recurrence and salvage surgery. American College of Radiology. ACR Appropriateness Criteria. (2000) (1)
The Feasibility of Radiation Therapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial (2021) (1)
DUCTAL CARCINOMA IN SITU (2014) (1)
1–29 Early Ipsilateral Breast Tumor Recurrences After Breast Conservation Affect Survival: An Analysis of the National Cancer Institute Randomized Trial (2006) (0)
Evaluation of current consensus panel guidelines for APBI: A pooled analysis of William Beaumont Hospital and American Society of Breast Surgeons MammoSite registry trial data. (2012) (0)
American Society of Breast Surgeons MammoSite® Registry: Ductal carcinoma in-situ subset – three-year data in 194 cancers (2008) (0)
P37 A comparative study of cyclooxygenase-2 expression in Korean and Caucasian patients with early-onset breast carcinoma (2005) (0)
Effect of Repeated Reperfusion on the Size of Experimental Myocardial infarction (1989) (0)
Evaluation of Second Malignancy and Local Recurrence in Patients with T1 and T2 Squamo Cell Carcinoma (scc) of the Larynx: 12:30 Pm (23) (2002) (0)
BAG-1: A N ovel B iomarker P redicting L ong-Term S urvival in E arly-Stage B reast C ancer (2001) (0)
BRCA1 Nuclear Export, a Novel Avenue to Render p53-Deficient Cancer Cell Susceptible to Ionizing Radiation and Cisplatin Induced Cytotoxicity (2005) (0)
Racial Disparities in Treatment Outcomes for African American Women with Ductal Carcinoma In Situ Receiving Whole Breast Irradiation following Breast Conserving Surgery (2010) (0)
Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey (2022) (0)
Autophagy Inhibition by Chloroquine Radiosensitizes Colorectal Cancer Cells to Radiation Therapy (2012) (0)
TU‐G‐BRC‐06: Patterns of Intra‐Fractional Motion and Uncertainties of Treatment Setup Reference Systems in Accelerated Partial Breast Irradiation of Right‐ and Left‐Sided Breast Cancer (2011) (0)
1–51 The prevalence of germline BRCA1 and BRCA2 mutations in young women with breast cancer undergoing breast-conservation therapy (2007) (0)
Local control, toxicity and cosmesis in women younger than 50 enrolled on the american society of breast surgeons mammosite® RTS registry trial (2008) (0)
Effect of oral propranolol on left ventricular performance in patients with ischemic heart disease. Ear densitographic study during uninterrupted treadmill exercise. (1982) (0)
SU‐GG‐J‐141: Optimization of Translational Corrections to Compensate For Rotational and Deformable Target Deviations in Image Guided Radiotherapy (2008) (0)
Adjuvant whole-abdominal radiation therapy in uterine papillary serous carcinoma (1990) (0)
Accelerated, Hypofractionated Whole-Breast Radiation Therapy in Women With Breast Cancer: A Phase 2 Trial (2014) (0)
SU‐GG‐T‐10: Experimental Measurement of Attenuation Factor of a New Type of Shielding Material for a HDR Ir‐192 Source (2008) (0)
Multidisciplinary Locoregional Management of Breast Cancer. (2020) (0)
Capecitabine (XEL) and Mitomycin-C (MMC) used concurrently with accelerated concomitant boost radiation therapy (CB-RT) in head and neck cancer (SCCHN): Preliminary results of a phase I clinical trial (2005) (0)
Low-risk Ductal Carcinoma In Situ (DCIS) Treated with Breast Conserving Surgery and Radiotherapy: Comparison with Intergroup Study E5194 (2009) (0)
Riluzole Increases Ionizing Radiation Related Cellular Toxicity in Metabotropic Glutamate Receptor 1 Positive Human Breast Cancer Cells (2010) (0)
Sorting out the Survival Impact of Radiation Therapy in Early-Stage Invasive Breast Cancer (2014) (0)
Academic radiation oncology faculty recruitment: a chair's perspective. (2014) (0)
In reply [7] (2005) (0)
Associated with Poor Outcome : A Tissue Microarray Study Alterations of Smad Signaling in Human Breast Carcinoma Are Updated (2002) (0)
Local recurrence versus new primary: A clinical pathologial analysis of 82 breast relapses (1992) (0)
41 Insulin growth factor-1 receptor (IGF-1R) expression as a prognostic indicator of local recurrence in conservatively treated breast cancer: A case-control study (1996) (0)
Abnormalities of 53BP1 in Basal-Like Breast Cancer. (2009) (0)
SU-E-J-41: Fluoroscopy Based Adaptive Setup Approach for Thoracic Cancer IGRT. (2012) (0)
Nomogram-Based Estimate of Axillary Nodal Involvement in ACOSOG Z0011 (Alliance): Validation and Association with Radiation Protocol Variations and Outcomes (2018) (0)
Five-Year Results of a Prospective Phase 2 Trial Evaluating Three-Week Hypofractionated Whole Breast Radiation Therapy with Boost (2018) (0)
Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole-Breast Irradiation (2019) (0)
Short Course, Two Day Accelerated Hypofractionated Partial Breast Balloon Brachytherapy: A Phase II Multi-Institutional Trial (2018) (0)
Breast-Conserving Therapy in Women with BRCA1/BRCA2-Associated Breast Cancer (2010) (0)
BRCA1/BRCA2 IN BREAST-CONSERVING THERAP. AUTHOR'S REPLY (1999) (0)
Key Breast Cancer Takeaways from ASTRO 2012 (2012) (0)
SU‐E‐J‐149: Heart Protection in Proton Therapy Using 4D Motion Analysis Based On Registration Between SENSE MRI and 4DCT (2013) (0)
The Prognostic Value of MDM2, MDM4 (MDMX), and p53 in Early Stage Breast Cancer Treated with Breast Conserving Surgery and Radiotherapy (2011) (0)
Outcomes after 125I Plaque Brachytherapy for Ocular Melanoma: The Yale Cancer Center Experience (2008) (0)
Efficient Double-Scattered Proton Treatment Delivery With a Patient Specific Bolus (2015) (0)
SU‐GG‐T‐13: Efficacy of the Fiducial Marker Based IGRT Approach in Prostate Tomotherapy and an Inter‐Fractional Motion Correction Optimization Method for Dose Coverage Improvement and Potential Margin Reduction (2010) (0)
Does the Use of Biozorb’ Result in Smaller Seroma Volume (boost CTV)? (2019) (0)
Formal Mentorship Programs Improves Overall Mentorship Experiences Among Radiation Oncology Residents (2019) (0)
Prognostic Implications of Mammographically Occult, Early Stage Breast Cancer Patients Treated with Breast Conservation Therapy (2008) (0)
Genetic Syndromes and Radiotherapy in Breast Cancer (2015) (0)
Abstract2002: Genetic Variants as Predictors of Late Adverse Radiotherapy Effects in Breast Cancer Patients (2006) (0)
2–51 Genomic Prediction of Locoregional Recurrence After Mastectomy in Breast Cancer (2007) (0)
Responses to concurrent radiotherapy and hormone-therapy and outcome for large breast cancers in post-menopausal women: Bollet MA, Kirova YM, Antoni G, et al (Institut Curie, Paris) Radiother Oncol 85:336-345, 2007§ (2008) (0)
The ubiquitin ligase TRIM21 regulates mutant p53 accumulation and gain of function in cancer (2023) (0)
Patterns of postmastectomy radiation therapy in clinically node-positive breast cancerpatients with pathologically negative lymph nodes after neoadjuvant chemotherapy. (2018) (0)
Key points in repeat breast-conservation therapy. (2009) (0)
MicroRNA profiling of triple negative breast cancer: predicting outcome and targets. (2009) (0)
Abstract P4-16-03: Patterns of failure after accelerated partial breast irradiation by consensus panel group: A pooled analysis of William Beaumont Hospital and the American Society of Breast Surgeons Trial data (2012) (0)
Trends in Hospital Owned Practices Within Radiation Oncology (2015) (0)
In Reply to Dr. Beal et al (2010) (0)
Networking (2021) (0)
SU‐E‐T‐639: Fast Beam Allocation Algorithm for Gamma Knife Based SRS Planning (2011) (0)
Intra-fractional Motions and Potential Margin Reduction in Accelerated Partial Breast Irradiation (APBI) (2009) (0)
Radiation Oncologists' Views on Breast Radiation Therapy Guidelines: Utilizing an Online Q&A Platform to Assess Current Views on Whole-Breast Irradiation Therapy. (2021) (0)
Outcome of primary radiation therapy versus primary surgery in stage III/IV squamous cell carcinoma of the oropharynx (2001) (0)
Motion Pattern for Liver Tumor and its Correlation to External Surrogates (2012) (0)
CHAPTER 10 Stage II breast cancer (2005) (0)
SU‐FF‐T‐324: On the Assay of Brachytherapy Sources (2007) (0)
Optimal PTV Margin in Patients with Fiducial Markers Treated with Accelerated Partial Breast Irradiation (APBI) using 3D-CRT: Final Results of CINJ 040801 (2011) (0)
Significance of Phospho(Ser73)-K8 Expression in Women With Breast Cancer of Triple Negative Phenotype (2014) (0)
Ambulatory Pulse Oximetry as a Clinical Aid in the Diagnosis of Radiation Pneumonitis (2012) (0)
DNA repair gene expression and risk of locoregional relapse in breast cancer patients: Le Scodan R, Cizeron-Clairac G, Fourme E, et al (Centre René Huguenin, Saint Cloud, France) Int J Radiat Oncol Biol Phys 78:328-336, 2010§ (2011) (0)
SU-FF-J-16: A Method to Determine the Necessity of Rotational Correction in Image Guided Radiotherapy (2007) (0)
A Free Form Deformation-based 3D Registration Algorithm for Image Guided Breast Radiotherapy (2009) (0)
Early Toxicity and Patient-Reported Cosmetic Outcomes in Patients Treated With Adjuvant Proton-Based Radiotherapy After Breast-Conserving Surgery. (2022) (0)
2021 Manuscript Reviewers: A Note of Thanks. (2022) (0)
Three-Fraction Accelerated Partial Breast Irradiation (APBI) Delivered With Interstitial Brachytherapy Is Safe: First Results From the Tri-fraction Radiation Therapy Used to Minimize Patient Hospital Trips (TRIUMPH-T) Trial. (2023) (0)
The Feasibility of Radiotherapy after Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial (2019) (0)
Parkin targets HIF-1α for ubiquitination and degradation to inhibit breast tumor progression (2017) (0)
Assessing the Quality of Radiation Oncology Residency Websites (2019) (0)
Radiation oncology: the new deal. (2003) (0)
LOCAL-REGIONAL RECURRENCE (LRR) AND SALVAGE SURGERY—BREAST CANCER (2013) (0)
Abstract GS4-01: Impact of Breast Conservation Therapy on Local Recurrence in Patients with Multiple Ipsilateral Breast Cancer – Results from ACOSOG Z11102 (Alliance) (2023) (0)
4. Sequence of Radiotherapy (RT) with Tamoxifen (TAM) in Conservatively Managed Breast Cancer (LRT) (2003) (0)
Toxicities and Locoregional Control After External Beam Chest Wall and/or Regional Lymph Node Re-irradiation for Recurrent Breast Cancer (2020) (0)
Acute Loco-regional Toxicity of a Novel Fractionation Scheme for Accelerated Partial Breast Irradiation (APBI) using 3D Conformal Radiotherapy (3D-CRT) (2010) (0)
Clinical Characteristics and Dose Volume Histogram Parameters Associated With Pleural Effusion in Non-Small Cell Lung Cancer Patients Treated With Chemoradiation Therapy (2015) (0)
A Comparative Study of Cyclooxygenase-2 Expression in Korean and Caucasian Patients with Early-Onset Breast Cancer (2005) (0)
The Effects of Abdominal Compression on the Motion and Volume of the GTV, Lungs, and Heart in Lung Cancer Patients (2013) (0)
Evaluation of Acute Toxicity in Patients Treated with Concurrent Bevacizumab and Radiotherapy (2009) (0)
93 The germline p53 13964 gc mutation confers resistance to radiation in familial breast cancer patients (1999) (0)
Christine (Cooky) O. Menias, MD, Named RSNA RadioGraphics Editor. (2020) (0)
A 4D Adaptive Approach to Improve Pretreatment Patient Positioning Accuracy in Lung Cancer Radiation Treatments (2012) (0)
An Emerging Role for Radiation Oncology in Precision Oncology (2016) (0)
Adaptive Lumpectomy Boost Planning Can Reduce Normal Tissue Exposure in Patients Receiving Hypofractionated Whole Breast Irradiation (2021) (0)
Is ipsilateral breast tumor recurrence an independent predictor of distant disease (1993) (0)
Correlation of Survival to CBCT-Based Tumor Response During Chemoradiation in Patients With Stage III Non-Small Cell Lung Cancer (2013) (0)
2110 Porfiromycin as an adjunct to radiation therapy in squamous cell carcinoma of the head and neck (1996) (0)
Targeting Regional Nodal Basins in Breast Cancer Patients: Exactly What Are We Treating? (2014) (0)
SU-FF-T-62: A Stereotactic System with a Non-Stereotactic Component: A New Perspective (2006) (0)
Genetic Factors in the Screening and Imaging for Breast Cancer (2023) (0)
Clinical Toxicity in Hypofractionated and Conventionally Fractionated Radiation in Breast Cancer Patients with Germline ATM Mutations (2022) (0)
A 35-year History of Radiation Therapy Utilization Across the United States (2012) (0)
Abstract P5-05-07: Foxo3a activation contributes to the synergy of imipridone and radiation in triple-negative breast cancer (2020) (0)
Abstract 691: Estrogen receptor mRNA level in breast cancer predicts response to tamoxifen (2012) (0)
Clinical efficacy of PARP inhibitors in breast cancer. (2023) (0)
The American Society for Radiation Oncology Workforce Taskforce Review of the United States Radiation Oncology Workforce Analysis. (2023) (0)
Abstract P4-16-09: Dosimetric feasibility and acute toxicity in a prospective trial of ultra-short course accelerated partial breast irradiation (APBI) using a multi-lumen balloon brachytherapy device (2012) (0)
Abstract 2765: Combination ONC201 and radiation therapy in the treatment of breast cancer (2018) (0)
419 Automated quantitative in-situ method of protein analysis (AQUA) demonstrates that components of the retinoblastoma (Rb) pathway are potential molecular targets in oropharyngeal squamous cell cancer (2004) (0)
SU‐FF‐I‐91: A Fast and Robust Dynamic Tracking Method of the Moving Deformable Targets in the Fluoroscopy Image Sequence for Image Guided Radiotherapy (2009) (0)
The American Society for Radiation Oncology Workforce Statement. (2022) (0)
Abstract LB-240: Circulating tumor cell (CTC) analysis in NRG oncology/RTOG 1014, repeat breast conserving treatment after in-breast recurrence (IBR) (2017) (0)
Precision Radiation Oncology: An Introduction (2019) (0)
Abstract P1-15-04: The adoption of hypofractionated whole breast irradiation for early-stage breast cancer: A national cancer data base analysis (2015) (0)
Intersociety Radiation Oncology Summit-SCOPE II. (2008) (0)
Neoadjuvant dose-dense (DD) concurrent doxorubicin (A) and docetaxel (T) for stage III breast cancer (BC). (2006) (0)
The Role of Fibronectin on Spatial Organization in 3D Culture: A Model for Wound Healing After Radiation Therapy (2014) (0)
Risk Factors for the Development of Clinical and Subclinical Lymphedema Detected by Bioimpedance Spectroscopy (2019) (0)
Prognostic Value of p16 Expression in Laryngeal Cancer Patients Treated with Radiation (2010) (0)
Abstract 2489: Targeting pro-survival BCL-2 family members increases radiation sensitivity in breast cancer cells (2011) (0)
Titel Page / Table of Contents / Guidelines for Authors / Imprint (2014) (0)
Breast Molecular Profiling and Radiotherapy Considerations. (2016) (0)
Radiotherapy and Regional Nodes (2018) (0)
Adjuvant Radiation Therapy Alone is Associated with Improved Overall Survival Compared to Hormonal Therapy Alone in Elderly Women with Favorable Early-Stage Breast Cancer (2019) (0)
Predictors of cosmesis in women enrolled on the American Society Of Breast Surgeons MammoSite® Registry Trial (2008) (0)
Abstract P5-07-08: Evaluating the risk of cardiotoxicity associated with concurrent trastuzumab emtansine (TDM1) and radiation therapy in patients with early-stage HER2 positive breast cancer (2023) (0)
Short-Course Accelerated Partial Breast Irradiation (Over 2 Days) Is Feasible With the Contura® Multi-Lumen Brachytherapy Device (2011) (0)
Variability of Tumor Motion in 4DCT: The Effects of Abdominal Compression on Lung Tumor Displacement (2012) (0)
Local Recurrence After Breast-Conserving Therapy in Patients With Multiple Ipsilateral Breast Cancer: Results From ACOSOG Z11102 (Alliance). (2023) (0)
Prognostic Impact of Missed Chemotherapy Doses During Chemoradiation Therapy for Unresectable Non-Small Cell Lung Cancer Patients (2015) (0)
Non-White Women Are as Likely as White Women to Receive Hypofractionated Radiation Therapy for Breast Cancer, But Less Likely to Enroll in Hypofractionation Clinical Trials (2013) (0)
Evaluation of second malignancy in patients with T1-T4 squamous cell carcinoma (SCC) of the larynx (2004) (0)
3506 Absence of the PALB2 229delT and 1592delT mutation in Korean patients with BRCA1/2 mutation negative breast cancers (2009) (0)
Invited commentary on 'Carbon footprint of the RSNA annual meeting'. (2020) (0)
Does kV Image Guidance for Bone Metastases Improve Pain Control? (2021) (0)
Time trends and geographic variation in the use of adjuvant radiotherapy for ductal carcinoma in situ (2004) (0)
SU‐GG‐J‐01: 3D‐3D Deformable Registration Based on Bifurcations of Tubular Organs for the 4D Computed Tomography (4DCT) Image Sets (2010) (0)
SP-0456: Locoregional management for triple negative breast cancer (2014) (0)
African Americans Face Significant Delays to Treatment After Diagnosis of Oropharyngeal Carcinoma (2012) (0)
Abstract 175: The Role of Fibronectin on Spatial Organization in 3D Culture (2015) (0)
APBI (Accelerated Partial-Breast Irradiation) Versus WBI (Whole-Breast Irradiation) Delivered with the Same Dose Fractionation: A Propensity Score Matched Analysis of Two Prospective Studied Cohorts (2019) (0)
2036 The natural history of local regional breast cancer recurrence: Prognosis and implications for systemic therapy (1997) (0)
Optimal Time for Initiation of Accelerated Partial Breast Irradiation (APBI) using 3-D Conformal Radiotherapy (3D-CRT) - Preliminary Analysis of CINJ 040801 (2009) (0)
Local therapy matters. (2009) (0)
Inhibition of Filamin-A Reduces Cancer Metastatic (2013) (0)
Fast 3-D Non-rigid CT and CBCT Registration in Head & Neck IGRT (2009) (0)
Extent of Axillary Dissection Predicts Survival in pN0 Early Stage Breast Cancer (2010) (0)
Dynamic Multileaf Collimation (dMLC) With Fluence Modulation for Whole Brain Radiotherapy (2007) (0)
Tamoxifen Confers a Limited Benefit in Older Women with Early Stage Breast Cancer (2010) (0)
Development of a noninvasive frame for fractionated stereotactic radiotherapy (1994) (0)
Excision and Reirradiation for Local Recurrence in Previously Treated Patient. (2019) (0)
ACR Appropriateness Criteria s Local-regional Recurrence (LR) and Salvage Surgery Breast Cancer (2014) (0)
Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. (2022) (0)
Three-Year Outcomes of a Once-Daily Fractionation Scheme for Accelerated Partial Breast Irradiation (APBI) Using 3-D Conformal Radiation Therapy (3D-CRT) (2013) (0)
2021 Manuscript Reviewers: A Note of Thanks. (2022) (0)
Incidence of clinical lymphedema in breast cancer patients treated with adjuvant proton-based radiotherapy (2022) (0)
Author reply (0)
628 poster SHORT-COURSE ACCELERATED PARTIAL BREAST IRRADIATION (OVER 2 DAYS) IS FEASIBLE WITH THE CONTURA(r) MULTI-LUMEN BRACHYTHERAPY DEVICE (2011) (0)
Patterns of Failure in Colorectal Patients With Liver Metastases Following Yttrium-90 Radioembolization (2012) (0)
Accelerated partial breast irradiation: the future of radiation therapy for breast cancer? (2013) (0)
Mastectomy First, Keeping Chemotherapy and Radiation in Reserve. (2019) (0)
3–53 Comparative study of lymphoedema with axillary node dissection versus axillary node sampling with radiotherapy in patients undergoing breast conservation surgery (2007) (0)
2064 Lumpectomy as salvage treatment of local recurrence following breast conserving management: Prognosis and factors predicting lumpectomy as a reasonable alternative to mastectomy (1999) (0)
Dose-painted Intensity Modulated Radiation Therapy May Offer Improved Morbidity as Compared to 3D-CRT (2012) (0)
Radiotherapy after Neoadjuvant Chemotherapy (2014) (0)
DNA Ploidy as a Significant Predictor of Recurrence‐Free Survival in Male Patients with Breast Cancer (1995) (0)
The Model of an ASTRO Servant Leader. (2021) (0)
Estrogen-Dependent Prognostic Significance of COX-2 in Early Stage Invasive Breast Cancer (2007) (0)
Race- and sex-based variation in industry research and general payments to medical oncologists in the United States. (2022) (0)
Setup uncertainties and the optimal imaging schedule in the prone position whole breast radiotherapy (2019) (0)
Short Course Accelerated Hypofractionated Partial Breast Balloon Brachytherapy (2018) (0)
Significance of tumor biology on local control in breast cancer. (2014) (0)
Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy (2023) (0)
Development of a Web-based Radiation Oncology Quality Improvement Initiation (ROQII) (2009) (0)
Is Lumpectomy with Tamoxifen (without RT) a Practical Option for Women 70 Years of Age or Older (2005) (0)
The role of postmastectomy radiotherapy in patients with stage II breast cancer (2018) (0)
Optimal management of patients with a positive sentinel lymph node (2009) (0)
Precision Radiation Oncology (2019) (0)
Six-year Analysis of Treatment-related Toxicities by the American Society of Breast Surgeons MammoSi (2011) (0)
Concurrent chemo-radiotherapy in operable breast cancer: Rouesse J, et al. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node positive breast cancer: final results.Int J Radiation Oncology Biol (2007) (0)
Abstract 689: Validation of antibodies to Estrogen Receptor ≤ and quantitative assessment of ERα1 and ERα5 expression in breast cancer (2012) (0)
Radiation Therapy for Breast Cancer from 1984 to the Present (2014) (0)
A Note of Thanks… (2021) (0)
Breast-Conserving Surgery in BRCA1/2 Mutation Carriers: Are We Approaching an Answer? (2010) (0)
SU-E-J-132: Lung Dose Reduction From Patient Specific 4D Motion Based Non-Uniform Dose Prescription in Lung IMRT Treatment (2013) (0)
Ipsilateral breast tumor recurrence (IBTR) following breast conservation therapy: Outcomes of salvage mastectomy (SM) vs. salvage breast conserving surgery (SBCS) and prognostic factors for salvage breast preservation (2004) (0)
Utilization of Breast Conserving Therapy in Stage 0, I, II Breast Cancer Patients in New Jersey: An American College of Surgeons National Cancer Database (NCDB) Analysis (2009) (0)
Christine (Cooky) O. Menias, MD, Named Editor of RadioGraphics. (2020) (0)
TH‐C‐304A‐05: A Fast Deformable Model Based 3D Registration Algorithm for Image Guided Prostate Radiotherapy (2009) (0)
Molecular prognostic markers in oropharyngeal squamous cell carcinoma; the role of C-met. (2004) (0)
Contents Vol. 9, 2014 (2014) (0)
2022 Manuscript Reviewers: A Note of Thanks. (2022) (0)
In Reply to Struikmans et al. (2022) (0)
In reply to Dr. Tiwana (2007) (0)
In reply to Leung. (2014) (0)
A novel approach to Verify air gap and SSD for proton radiotherapy using surface imaging (2019) (0)
SU‐FF‐T‐80: Incorporation of Isodose‐Level Control to a Simplified Intensity‐Modulated Radiation Therapy (sIMRT) Technique for Whole Breast Radiotherapy (2005) (0)
Abstract 5763: VCAM1 mediates aggressive bone metastasis outbreak from tumor dormancy by engaging α4β1-positive osteoclast progenitor cells (2010) (0)
ATM Sequence Variants as Predictors for Late Normal Tissue Responses in Breast Cancer Patients Treated with Radiotherapy (2005) (0)
Abstract P6-16-02: Cost-effectiveness of endocrine therapy or radiation treatment alone or in combination for standard- and good-risk DCIS (2020) (0)
Radiation Therapy for Triple-Negative Breast Cancer (2018) (0)
Breast Conservation Therapy and BRCA Status Do Not Predict for Poor Outcomes in Young Women with Early-stage Breast Cancer (2010) (0)
Patterns of post-mastectomy radiation therapy in clinically node positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy. (2021) (0)
Abstract P4-12-20: Early toxicity and patient-reported cosmetic outcomes in patients treated with adjuvant proton-based radiotherapy after breast-conserving surgery (2020) (0)
The effect of BMI-1 inhibition on brain cancer stem cells. (2012) (0)
Nailing the Clavicular Head: Assuring Adequate Coverage of the Medial/Inferior Aspect of the Supraclavicular Space in Patients Receiving Regional Nodal Radiation Therapy for Breast Cancer. (2022) (0)
Abstract OT-32-02: Irene study: Phase 2 study of incmga00012 (retifanlimab)and the oncolytic virus pelareorep in metastatic triple negative breast cancer (2021) (0)
Abstract of ASTRO scientific paper to be presentedRegional nodal irradiation in the conservative treatment of breast cancer (1989) (0)
Expert consultations in breast cancer (2016) (0)
2022 RSNA Outstanding Researcher. (2022) (0)
Effect of addition of paclitaxel on radiotherapy delivery and locoregional control of node positive breast cancer: Cancer and Leukemia Group B 9344 (2005) (0)
Ask the Experts: Accelerated partial breast irradiation: the future of radiation therapy for breast cancer? (2013) (0)
Controversial Indications for Breast Conserving Therapy and Radiation (2010) (0)
DEAD box 1 (DDX1) Expression Predicts for Local Control and Overall Survival in Early-stage, Node-negative Breast Cancer Treated with Breast Conserving Surgery and Radiation Therapy (2011) (0)
Safety of breast conservation therapy in BRCA1 and BRCA2 cancers (2004) (0)
Overexpression of Excision Repair Cross Complementing-1 Gene May Predict Local Recurrence After Definitive Chemoradiation for Unresectable Non-Small Cell Lung Cancer (2015) (0)
Is There a Role for Postmastectomy Radiation Therapy After Complete Pathologic Response to Neoadjuvant Chemotherapy? (2014) (0)
SU‐E‐T‐238: OnedosePlus MOSFET Dosimeter Performance in Tangential Field in Vivo Dosimtery (2011) (0)
Comparison of Radiation-Induced Fatigue using 3 Fractionation Schedules in Breast Radiotherapy (2010) (0)
Mounting Evidence for Postmastectomy Locoregional Radiation Therapy (2017) (0)
Implications of a Negative Sentinel Node on Radiation Field Design for Chest Wall Recurrences (2016) (0)
Roles of BCCIP deficiency in mammary tumorigenesis (2017) (0)
PO-1016: Parameterization of Ir-192 HDR source phase space file for Monte Carlo based dose calculation (2014) (0)
Prognostic Value of P53 Expression in Patients Treated with Breast Conserving Therapy (2009) (0)
Effect of Addition of Adjuvant Paclitaxel on Radiotherapy Delivery and Locoregional Control of Node-Positive Breast Cancer: Cancer and Leukemia Group B 9344 (2005) (0)
4-31-01 Total lymphoid irradiation and low dose corticosteroids in progressive MS (1997) (0)
Post-mastectomy Radiation, All in. (2018) (0)
Benefits of Adding Acyclovir to Chemoradiation in a Nasopharyngeal Cancer Cell Line with the Epstein Barr Virus Genome Intact (2016) (0)
Acyclovir Improves the Efficacy of Chemoradiation in Nasopharyngeal Cancer Containing the Epstein Barr Virus Genome (2020) (0)
PO-1297: Utilization of Radiation Therapy and Predictors of Noncompliance among Syrian Refugees in Turkey (2020) (0)
A Quantitative Study of the Correlations of Lung Tumor Motion to Cardiac and Respiratory Motion (2012) (0)
TH‐D‐213A‐06: Meshless Deformable Model Based 3d Registration of Prostate Image Guided Radiotherapy (2009) (0)
Reconstruction Outcomes in a Multi-Institution Prospective Phase II Hypofractionated Post-Mastectomy Radiation Therapy Trial (2020) (0)
BCCIP: A novel marker for radiotherapy benefit in patients with laryngeal cancer (2007) (0)
Tailoring cancer radiotherapy through genotyping, how close are we? (2015) (0)
Targeting Prosurvival Bcl-2 Family Members Increases Radiation Sensitivity in Breast Cancer Cells (2010) (0)
Long-term results for women with mammographically detected ductal carcinoma in-situ of the breast treated with breast-conserving surgery and definitive breast irradiation (2003) (0)
SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2 (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bruce George Haffty?

Bruce George Haffty is affiliated with the following schools:

Yale University
University of Queensland
Rutgers University
University of Wisconsin–Madison
University of Medicine and Dentistry of New Jersey
University of Toronto
University of Utah